MENU
ADCT
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ADC Therapeutics SA (ADCT) Earnings Date & Reports

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more

A.I. Advisor
published Earnings

ADCT is expected to report earnings to rise 81.82% to -40 cents per share on August 12

ADC Therapeutics SA ADCT Stock Earnings Reports
Q2'25
Est.
$-0.40
Q1'25
Beat
by $0.18
Q4'24
Beat
by $0.18
Q3'24
Beat
by $0.10
Q2'24
Beat
by $0.08
The last earnings report on May 14 showed earnings per share of -21 cents, beating the estimate of -40 cents. With 637.35K shares outstanding, the current market capitalization sits at 341.17M.
View a ticker or compare two or three
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com